<?xml version='1.0' encoding='utf-8'?>
<document id="22227272"><sentence text="Lamotrigine is a substrate for OCT1 in brain endothelial cells."><entity charOffset="0-11" id="DDI-PubMed.22227272.s1.e0" text="Lamotrigine" /></sentence><sentence text="The mechanisms that underpin the passage of lamotrigine at the blood-brain barrier to its site of action in the brain is poorly understood"><entity charOffset="44-55" id="DDI-PubMed.22227272.s2.e0" text="lamotrigine" /></sentence><sentence text=" Lamotrigine has been postulated to be delivered to its site of action in the brain favourably despite its physicochemical properties"><entity charOffset="1-12" id="DDI-PubMed.22227272.s3.e0" text="Lamotrigine" /></sentence><sentence text=" The aim of this study was to investigate the transport of lamotrigine in an in-vitro model of the BBB"><entity charOffset="59-70" id="DDI-PubMed.22227272.s4.e0" text="lamotrigine" /></sentence><sentence text=" In this study, lamotrigine was found to have a distribution coefficient of 0 at pH 7"><entity charOffset="16-27" id="DDI-PubMed.22227272.s5.e0" text="lamotrigine" /></sentence><sentence text="4 indicating that it was not highly lipophilic" /><sentence text=" Human brain endothelial cells (hCMEC/D3) were used to probe the interaction of lamotrigine with drug transporters"><entity charOffset="80-91" id="DDI-PubMed.22227272.s7.e0" text="lamotrigine" /></sentence><sentence text=" The uptake of lamotrigine into hCMEC/D3 cells was found to be an active process (K(m) = 62 ± 14 μM; V(max) = 385 ± 30 pmol/min/million cells)"><entity charOffset="15-26" id="DDI-PubMed.22227272.s8.e0" text="lamotrigine" /></sentence><sentence text=" Furthermore, use of a panel of transporter inhibitors indicated that this active uptake was mediated by organic cation transporter 1 (OCT1)" /><sentence text=" OCT1 mRNA and protein were shown to be expressed in hCMEC/D3 cells" /><sentence text=" KCL22 cells overexpressing OCT1 were then used to validate these findings" /><sentence text=" Lamotrigine was confirmed to be a substrate and inhibitor in OCT1-transfected KCL22 cells"><entity charOffset="1-12" id="DDI-PubMed.22227272.s12.e0" text="Lamotrigine" /></sentence><sentence text=" A putative pharmacokinetic drug-drug interaction (DDI) between quetiapine and lamotrigine was recently reported in patients and we show here that quetiapine is a potent inhibitor of the OCT1-mediated transport of lamotrigine"><entity charOffset="64-74" id="DDI-PubMed.22227272.s13.e0" text="quetiapine" /><entity charOffset="79-90" id="DDI-PubMed.22227272.s13.e1" text="lamotrigine" /><entity charOffset="147-157" id="DDI-PubMed.22227272.s13.e2" text="quetiapine" /><entity charOffset="214-225" id="DDI-PubMed.22227272.s13.e3" text="lamotrigine" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e0" e2="DDI-PubMed.22227272.s13.e0" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e0" e2="DDI-PubMed.22227272.s13.e1" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e0" e2="DDI-PubMed.22227272.s13.e2" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e0" e2="DDI-PubMed.22227272.s13.e3" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e1" e2="DDI-PubMed.22227272.s13.e1" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e1" e2="DDI-PubMed.22227272.s13.e2" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e1" e2="DDI-PubMed.22227272.s13.e3" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e2" e2="DDI-PubMed.22227272.s13.e2" /><pair ddi="false" e1="DDI-PubMed.22227272.s13.e2" e2="DDI-PubMed.22227272.s13.e3" /></sentence><sentence text=" This is the first time that a specific influx transporter has been shown to transport lamotrigine"><entity charOffset="87-98" id="DDI-PubMed.22227272.s14.e0" text="lamotrigine" /></sentence><sentence text=" The clinical implications of these findings with respect to the efficacy of lamotrigine and its potential for DDI require further investigation"><entity charOffset="77-88" id="DDI-PubMed.22227272.s15.e0" text="lamotrigine" /></sentence><sentence text="" /></document>